Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

EPO grants Sonnet EU Patent No. EP3583125 B1 for Fully Human Albumin Binding (FHAB®) domain fusion proteins, expanding global IP protection. Sonnet BioTherapeutics Holdings, Inc. announced that ...

Albumin use in patients with septic shock who had kidney impairment was associated with increased RRT (OR, 2.37) and with in-hospital mortality (OR, 1.21). Caution is urged with early albumin use ...

Attribution (BY): Credit must be given to the creator. The binding ability of human serum albumin (HSA) on active pharmaceutical ingredients (APIs) is one of the most important parameters in the early ...